U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387679) titled 'Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity' on Jan. 26.
Brief Summary: There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.
Study Start Date: Nov. 29, 2024
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovarian Syndrome
Intervention:
DRUG: Myo-inositol
Women were given tablet myo-inositol 1 gm twice a day for 3 months.
DRUG: M...